| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Medicus Pharma Ltd.
13D
MDCX · 58471K202
|
5.3% |
9/14/2026
Event 9/4/2026
|
||||
| Bokhari, Raza | 5.3% | |||||
| RBx Capital, LP | 0.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.